|
|
| calgb.org > CALGB Results Summaries |
| CALGB Results Summaries |
| The Cancer and Leukemia Group B is working to make results of CALGB studies more accessible to those touched by cancer and others interested in cancer research in a reader-friendly format. Summaries highlight recently published results and provide resources for more details. To find summaries, search by type of cancer. |
| Committee Short Cuts |
| Breast |
|
CALGB 9840 – A phase III study of paclitaxel via weekly 1 hour infusion versus standard 3 hour infusion every 3 weeks with Herceptin (trastuzumab) (NSC #688097) in the treatment of patients with/without HER-2/neu-overexpressing metastatic breast cancer CALGB 49907—A randomized trial of adjuvant chemotherapy with standard regimens, cyclophosphamide, methotrexate and fluorouracil – (CMF) or doxorubicin and cyclophosphamide – (AC), versus capecitabine in women 65 years and older with node positive or node-negative breast cancer |
| Cancer Control and Health Outcomes |
| Cancer in the Elderly |
| Correlative Sciences for Solid Tumors |
| Gastrointestinal |
| Genitourinary |
| Leukemia |
| Leukemia Correlative Sciences |
| Lymphoma |
| Oncology Nursing |
| Pharmacology and Experimental Therapeutics |
| Respiratory |
| Surgery |
| Transplant |
|
|
CALGB Newsletter
|
|
|||
|
